Celgene Corp Receivables Turnover Ratio (CELG), from the third quarter 2019 to the third quarter 2018 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Celgene Corp  (NASDAQ: CELG)
 

Celgene Accounts Receivables Turnover Ratio from the third quarter 2019 to the third quarter 2018

Quarterly Results, Trends, Rankings, Statistics


Celgene Corp's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2019 to a ratio of 7.37, this is below the company average, and notable indication of worsening business environment. Average collection period, for Celgene's accounts receivable remained unchanged at 50 days, in the Sep 30 2019 quarter.

If we take a look into Healthcare sector 214 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 1885, from overall ranking in the second quarter 2019 at 2319.

What is Receivable Turnover Ratio?
What is Celgene Corp Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CELG Receivables Turnover Ratio (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter
Y / Y Receivable Change 11.98 % 18.75 % 16.88 % 7.55 % 16.74 %
Y / Y Revenue Change 16.14 % 15.36 % 13.76 % 15.91 % 18.41 %
Receivable Turnover Ratio (TTM) 7.37 7.3 7.35 7.42 7.28
CELG's Total Ranking # 1885 # 2319 # 2043 # 2319 # 1795
Accounts Receivable average collection period days 50 50 50 49 50
Seq. Receivable Change -3.14 % 5.33 % 12.63 % -2.55 % 2.71 %
Seq. Revenue Change 2.73 % 9.32 % -0.3 % 3.73 % 2.05 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 91
Healthcare Sector # 215
Overall Market # 1885

Receivable Turnover Ratio Statistics
High Average Low
27.57 7.86 5.61
(Dec. 31, 2005)   (March 31, 2012)





CELG Company Profile • Back to CELG Efficiency Comparisons • Compare CELG Receivables Turnover Ratio to its Competitors

Financial Statements
Celgene's Accounts Receivable $ 2,374 Millions Visit CELG's Balance sheet
Celgene's Sales TTM $ 16,982 Millions Visit CELG's Income Statement
Sources of CELG's Revenues Visit CELG's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CELG's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CELG's Growth Rates CELG's Roa CELG's Inventory Turnover Ratio CELG's Dividend Comparisons
CELG's Profitability Ratios CELG's Roi CELG's Asset Turnover Ratio CELG's Dividend Growth
CELG's Valuation Ratios CELG's Roe CELG's Financial Strength Ratios CELG's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2019, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2019 Receivable at quarter ending Sep 30 2019
Lexicon Pharmaceuticals Inc   18.17 $ 330.417  Millions$ 18.184  Millions
Allarity Therapeutics Inc   16.39 $ 0.058  Millions$ 0.004  Millions
Waters Corporation  16.25 $ 2,405.321  Millions$ 148.015  Millions
Aveo Pharmaceuticals Inc   16.18 $ 29.514  Millions$ 1.825  Millions
Vtv Therapeutics Inc   15.89 $ 7.279  Millions$ 0.458  Millions
Therapeutic Solutions International Inc   15.46 $ 0.021  Millions$ 0.001  Millions
Chemed Corporation  15.31 $ 1,873.739  Millions$ 122.418  Millions
Cv Sciences Inc   15.28 $ 58.592  Millions$ 3.835  Millions
Seres Therapeutics Inc   15.02 $ 37.512  Millions$ 2.497  Millions
Mannkind Corporation  14.98 $ 63.076  Millions$ 4.211  Millions
Kyntra Bio Inc   14.96 $ 356.657  Millions$ 23.846  Millions
Jrsis Health Care Corp  14.77 $ 30.719  Millions$ 2.079  Millions
Ainos Inc   14.72 $ 0.015  Millions$ 0.001  Millions
Plx Pharma Inc   14.55 $ 0.829  Millions$ 0.057  Millions
Bespoke Extracts Inc  14.51 $ 0.062  Millions$ 0.004  Millions
Corcept Therapeutics Inc  14.45 $ 285.422  Millions$ 19.746  Millions
Neurometrix Inc   13.67 $ 11.294  Millions$ 0.826  Millions
Musclepharm Corporation  13.63 $ 82.413  Millions$ 6.048  Millions
Verastem Inc   13.51 $ 15.049  Millions$ 1.114  Millions
Talphera Inc   13.21 $ 2.427  Millions$ 0.184  Millions
Immucell Corporation  12.92 $ 13.028  Millions$ 1.008  Millions
Otonomy Inc   12.83 $ 0.715  Millions$ 0.056  Millions
Reflect Scientific Inc  12.57 $ 1.410  Millions$ 0.112  Millions
Parallax Health Sciences Inc   12.51 $ 0.079  Millions$ 0.006  Millions
Rafael Holdings Inc  12.22 $ 5.006  Millions$ 0.410  Millions
Lifeloc Technologies Inc   12.09 $ 8.715  Millions$ 0.721  Millions
Travere Therapeutics Inc   11.97 $ 172.421  Millions$ 14.399  Millions
La Jolla Pharmaceutical Company  11.95 $ 19.988  Millions$ 1.673  Millions
Zynex inc   11.84 $ 40.647  Millions$ 3.433  Millions
Integrated Biopharma Inc  11.83 $ 51.079  Millions$ 4.317  Millions

Date modified: 2026-09-08T15:09:41+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.